Literature DB >> 14963477

Gabapentin in the management of the recurrent, refractory, idiopathic priapism.

P Perimenis1, A Athanasopoulos, P Papathanasopoulos, G Barbalias.   

Abstract

Recurrent idiopathic priapism is a difficult problem to treat and a true emergency for the physicians, and often even invasive therapeutic interventions fail. We recently managed three men with refractory idiopathic priapism with oral gabapentin. They responded to treatment within 48 h. Two men continue not to experience prolonged erections while treated with lower doses of gabapentin for 16 and 24 months, respectively. The third, after a successful treatment for 6 months, stopped gabapentin and priapism recurred. He responded to treatment again and continues to be free of episodes for 9 months. Gabapentin may be a safe alternative for the management of refractory idiopathic priapism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14963477     DOI: 10.1038/sj.ijir.3901165

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  9 in total

Review 1.  Recent advances in the medical and surgical treatment of priapism.

Authors:  Adam Shrewsberry; Aaron Weiss; Chad W M Ritenour
Journal:  Curr Urol Rep       Date:  2010-11       Impact factor: 3.092

Review 2.  Evaluation and management of priapism: 2009 update.

Authors:  Yun-Ching Huang; Ahmed M Harraz; Alan W Shindel; Tom F Lue
Journal:  Nat Rev Urol       Date:  2009-05       Impact factor: 14.432

Review 3.  Medical management of ischemic stuttering priapism: a contemporary review of the literature.

Authors:  Helen R Levey; Omer Kutlu; Trinity J Bivalacqua
Journal:  Asian J Androl       Date:  2011-11-07       Impact factor: 3.285

Review 4.  Management of priapism: an update for clinicians.

Authors:  Helen R Levey; Robert L Segal; Trinity J Bivalacqua
Journal:  Ther Adv Urol       Date:  2014-12

Review 5.  Contemporary best practice in the evaluation and management of stuttering priapism.

Authors:  Georgios Kousournas; Asif Muneer; David Ralph; Evangelos Zacharakis
Journal:  Ther Adv Urol       Date:  2017-07-04

Review 6.  Priapism in hematological and coagulative disorders: an update.

Authors:  Belinda F Morrison; Arthur L Burnett
Journal:  Nat Rev Urol       Date:  2011-03-15       Impact factor: 14.432

Review 7.  Review of Ischemic and Non-ischemic Priapism.

Authors:  Mark G Biebel; Martin S Gross; Ricardo Munarriz
Journal:  Curr Urol Rep       Date:  2022-05-10       Impact factor: 3.092

Review 8.  Medical and surgical management of priapism.

Authors:  J Cherian; A R Rao; A Thwaini; F Kapasi; I S Shergill; R Samman
Journal:  Postgrad Med J       Date:  2006-02       Impact factor: 2.401

9.  Essential thrombocythemia with (type2) calreticulin presented as stuttering priapism case report and review of literature.

Authors:  Elrazi Awadelkarim Ali; Abdulqadir Jeprel Nashwan; Mohamed A Yassin
Journal:  Clin Case Rep       Date:  2020-11-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.